000			01591 a2200457 4500
005			20250514010050.0
264		0	_c20011025
008			200110s 0 0 fre d
022			_a1295-0661
040			_aNLM _beng _cNLM
100	1		_aTremblay, J P
245	0	0	_a[Transplantation of normal or genetically modified myoblasts for the treatment of hereditary or acquired diseases]. _h[electronic resource]
260			_bJournal de la Societe de biologie _c2001
300			_a29-37 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAnimals
650	0	4	_aCell Transplantation
650	0	4	_aCellular Senescence
650	0	4	_aClinical Trials as Topic
650	0	4	_aGraft Enhancement, Immunologic
650	0	4	_aGraft Survival
650	0	4	_aHaplorhini
650	0	4	_aHematopoietic Stem Cell Transplantation
650	0	4	_aHumans
650	0	4	_aImmune Tolerance
650	0	4	_aImmunosuppression Therapy _xadverse effects
650	0	4	_aImmunosuppressive Agents _xtherapeutic use
650	0	4	_aMetalloendopeptidases _xgenetics
650	0	4	_aMice
650	0	4	_aMice, Inbred mdx
650	0	4	_aMinor Histocompatibility Antigens _ximmunology
650	0	4	_aMuscle, Skeletal _xcytology
650	0	4	_aMuscular Diseases _xgenetics
650	0	4	_aMuscular Dystrophies _xtherapy
650	0	4	_aMuscular Dystrophy, Animal _xtherapy
650	0	4	_aTacrolimus _xtherapeutic use
650	0	4	_aTransfection
650	0	4	_aTreatment Failure
700	1		_aVilquin, J T
773	0		_tJournal de la Societe de biologie _gvol. 195 _gno. 1 _gp. 29-37
999			_c11454471 _d11454471